Myeloid-derived suppressor cells are involved in lysosomal acid lipase deficiency-induced endothelial cell dysfunctions

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1942-1953

  Zhao, Ting ^a   Ding, Xinchun ^a   Du, Hong ^a,b   Yan, Cong ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID LIPASE; CD31 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME DEFICIENCY; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYSOSOMAL ACID LIPASE DEFICIENCY; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; WILD TYPE;

ANIMALS; ANTIGENS, CD31; ANTIGENS, LY; APOPTOSIS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; STEROL ESTERASE; TOR SERINE-THREONINE KINASES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WOLMAN DISEASE;

EID: 84905980360     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301941     Document Type: Article

References (58)

1. Lian, X. , C. Yan, L. Yang, Y. Xu, and H. Du. 2004. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L801-L807.
2. Lian, X. , C. Yan, Y. Qin, L. Knox, T. Li, and H. Du. 2005. Neutral lipids and peroxisome proliferator-activated receptor-gamma control pulmonary gene expression and inflammation-triggered pathogenesis in lysosomal acid lipase knockout mice. Am. J. Pathol. 167: 813-821.
3. Pober, J. S. , and W. C. Sessa. 2007. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7: 803-815.
4. Sica, A. , and V. Bronte. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117: 1155-1166.
5. Ostrand-Rosenberg, S. , and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
6. Gabrilovich, D. I. , and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
7. Pan, P. Y. , G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S. H. Chen. 2008. Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 111: 219-228.
8. Yang, L. , L. M. DeBusk, K. Fukuda, B. Fingleton, B. Green-Jarvis, Y. Shyr, L. M. Matrisian, D. P. Carbone, and P. C. Lin. 2004. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6: 409-421.
9. Kujawski, M. , M. Kortylewski, H. Lee, A. Herrmann, H. Kay, and H. Yu. 2008. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Invest. 118: 3367-3377.
10. Qu, P. , W. C. Shelley, M. C. Yoder, L. Wu, H. Du, and C. Yan. 2010. Critical roles of lysosomal acid lipase in myelopoiesis. Am. J. Pathol. 176: 2394-2404.
11. Wu, L. , H. Du, Y. Li, P. Qu, and C. Yan. 2011. Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis. Am. J. Pathol. 179: 2131-2141.
12. Yan, C. , X. Lian, Y. Li, Y. Dai, A. White, Y. Qin, H. Li, D. A. Hume, and H. Du. 2006. Macrophage-specific expression of human lysosomal acid lipase corrects inflammation and pathogenic phenotypes in lal-/-mice. Am. J. Pathol. 169: 916-926.
13. Ding, X. , H. Du, M. C. Yoder, and C. Yan. 2014. Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/-mice. Am. J. Pathol. 184: 397-408.
14. Zhao, T. , H. Du, X. Ding, K. Walls, and C. Yan. 2014. Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal2/2 mice. Oncogene DOI: 10. 1038/onc. 2014. 143.
15. Guertin, D. A. , and D. M. Sabatini. 2007. Defining the role of mTOR in cancer. Cancer Cell 12: 9-22.
16. Dormond, O. , J. C. Madsen, and D. M. Briscoe. 2007. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J. Biol. Chem. 282: 23679-23686.
17. Yan, C. , X. Ding, N. Dasgupta, L. Wu, and H. Du. 2012. Gene profile of myeloid-derived suppressive cells from the bone marrow of lysosomal acid lipase knock-out mice. PLoS ONE 7: e30701.
18. Dong, Q. G. , S. Bernasconi, S. Lostaglio, R. W. De Calmanovici, I. Martin-Padura, F. Breviario, C. Garlanda, S. Ramponi, A. Mantovani, and A. Vecchi. 1997. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17: 1599-1604.
19. Fehrenbach, M. L. , G. Cao, J. T. Williams, J. M. Finklestein, and H. M. Delisser. 2009. Isolation of murine lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L1096-L1103.
20. Wu, L. , C. Yan, M. Czader, O. Foreman, J. S. Blum, R. Kapur, and H. Du. 2012. Inhibition of PPARg in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis. Blood 119: 115-126.
21. Zhang, X. , R. Goncalves, and D. M. Mosser. 2008. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14: Unit 14. 11.
22. Zhao, T. , J. Li, and A. F. Chen. 2010. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 299: E110-E116.
23. Hamada, H. , M. K. Kim, A. Iwakura, M. Ii, T. Thorne, G. Qin, J. Asai, Y. Tsutsumi, H. Sekiguchi, M. Silver, et al. 2006. Estrogen receptors a and b mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114: 2261-2270.
24. Liang, C. -C. , A. Y. Park, and J. -L. Guan. 2007. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2: 329-333.
25. Bonauer, A. , G. Carmona, M. Iwasaki, M. Mione, M. Koyanagi, A. Fischer, J. Burchfield, H. Fox, C. Doebele, K. Ohtani, et al. 2009. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.
26. Qu, P. , H. Du, D. S. Wilkes, and C. Yan. 2009. Critical roles of lysosomal acid lipase in T cell development and function. Am. J. Pathol. 174: 944-956.
27. Muller, W. A. 2009. Mechanisms of transendothelial migration of leukocytes. Circ. Res. 105: 223-230.
28. Qu, P. , H. Du, X. Wang, and C. Yan. 2009. Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res. 69: 7252-7261.
29. Qu, P. , C. Yan, J. S. Blum, R. Kapur, and H. Du. 2011. Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/-mice. J. Immunol. 187: 3854-3866.
30. Qu, P. , H. Du, Y. Li, and C. Yan. 2009. Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung. J. Immunol. 182: 1648-1659.
31. Shi, C. , and E. G. Pamer. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11: 762-774.
32. Pasceri, V. , J. S. Cheng, J. T. Willerson, and E. T. H. Yeh. 2001. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. [Published erratum appears in 2001. Circulation 104: 1992. ] Circulation 103: 2531-2534.
33. Lo, C. -W. , M. -W. Chen, M. Hsiao, S. Wang, C. -A. Chen, S. -M. Hsiao, J. -S. Chang, T. -C. Lai, S. Rose-John, M. -L. Kuo, and L. -H. Wei. 2011. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res. 71: 424-434.
34. Jöhrer, K. , K. Janke, J. Krugmann, M. Fiegl, and R. Greil. 2004. Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-A via TNF receptor 2 and autocrine up-regulation of MCP-1. Clin. Cancer Res. 10: 1901-1910.
35. Arnaoutova, I. , and H. K. Kleinman. 2010. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat. Protoc. 5: 628-635.
36. Lamalice, L. , F. Le Boeuf, and J. Huot. 2007. Endothelial cell migration during angiogenesis. Circ. Res. 100: 782-794.
37. Gerber, H. -P. , A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit, and N. Ferrara. 1998. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 39-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273: 30336-30343.
38. Coultas, L. , K. Chawengsaksophak, and J. Rossant. 2005. Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
39. Choi, J. , D. R. Enis, K. P. Koh, S. L. Shiao, and J. S. Pober. 2004. T lymphocyteendothelial cell interactions. Annu. Rev. Immunol. 22: 683-709.
40. Wheway, J. , S. Obeid, P. O. Couraud, V. Combes, and G. E. Grau. 2013. The brain microvascular endothelium supports T cell proliferation and has potential for alloantigen presentation. PLoS ONE 8: e52586.
41. Hay, N. , and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18: 1926-1945.
42. Muller, W. 2007. PECAM: Regulating the start of diapedesis. In Adhesion Molecules: Function and Inhibition. K. Ley, ed. Birkhäuser, Basel, Switzerland, p. 201-220.
43. Thelen, M. , and J. V. Stein. 2008. How chemokines invite leukocytes to dance. Nat. Immunol. 9: 953-959.
44. Shulman, Z. , and R. Alon. 2012. Real-time analysis of integrin-dependent transendothelial migration and integrin-independent interstitial motility of leukocytes. Methods Mol. Biol. 757: 31-45.
45. Liao, F. , H. K. Huynh, A. Eiroa, T. Greene, E. Polizzi, and W. A. Muller. 1995. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182: 1337-1343.
46. Huang, M. T. , K. Y. Larbi, C. Scheiermann, A. Woodfin, N. Gerwin, D. O. Haskard, and S. Nourshargh. 2006. ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood 107: 4721-4727.
47. Woodfin, A. , M. B. Voisin, B. A. Imhof, E. Dejana, B. Engelhardt, and S. Nourshargh. 2009. Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood 113: 6246-6257.
48. Deshmane, S. L. , S. Kremlev, S. Amini, and B. E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29: 313-326.
49. Folkman, J. 2003. Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3: 643-651.
50. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932-936.
51. Auerbach, R. , R. Lewis, B. Shinners, L. Kubai, and N. Akhtar. 2003. Angiogenesis assays: a critical overview. Clin. Chem. 49: 32-40.
52. Du, H. , M. Heur, M. Duanmu, G. A. Grabowski, D. Y. Hui, D. P. Witte, and J. Mishra. 2001. Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J. Lipid Res. 42: 489-500.
53. Li, W. , M. Petrimpol, K. D. Molle, M. N. Hall, E. J. Battegay, and R. Humar. 2007. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2. Circ. Res. 100: 79-87.
54. Laplante, M. , and D. M. Sabatini. 2012. mTOR Signaling in Growth Control and Disease. Cell 149: 274-293.
55. Kim, G. D. , J. Oh, L. S. Jeong, and S. K. Lee. 2013. Thio-Cl-IB-MECA, a novel A adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells. Biochem. Biophys. Res. Commun. 437: 79-86.
56. Du, H. , S. Schiavi, M. Levine, J. Mishra, M. Heur, and G. A. Grabowski. 2001. Enzyme therapy for lysosomal acid lipase deficiency in the mouse. Hum. Mol. Genet. 10: 1639-1648.
57. Du, H. , M. Heur, D. P. Witte, D. Ameis, and G. A. Grabowski. 2002. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice. Hum. Gene Ther. 13: 1361-1372.
58. Du, H. , T. L. Cameron, S. J. Garger, G. P. Pogue, L. A. Hamm, E. White, K. M. Hanley, and G. A. Grabowski. 2008. Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J. Lipid Res. 49: 1646-1657.